Stryker Corporation $SYK Shares Sold by LaFleur & Godfrey LLC

Posted by Brenda Bartman on May 6th, 2026

LaFleur & Godfrey LLC decreased its holdings in Stryker Corporation (NYSE:SYK – Free Report) by 2.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 70,840 shares of the medical technology company’s stock after selling 1,879 shares during the period. Stryker makes up approximately 3.0% of LaFleur & Godfrey LLC’s investment portfolio, making the stock its 8th largest position. LaFleur & Godfrey LLC’s holdings in Stryker were worth $24,898,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Brighton Jones LLC grew its holdings in shares of Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock worth $1,643,000 after purchasing an additional 609 shares during the period. Schnieders Capital Management LLC. purchased a new stake in Stryker in the 2nd quarter valued at about $205,000. Marshall Wace LLP lifted its position in Stryker by 107.9% in the second quarter. Marshall Wace LLP now owns 5,700 shares of the medical technology company’s stock valued at $2,255,000 after buying an additional 77,831 shares during the last quarter. Nebula Research & Development LLC purchased a new position in Stryker during the second quarter worth about $219,000. Finally, HUB Investment Partners LLC purchased a new position in Stryker during the second quarter worth about $253,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Stryker Trading Up 1.5%

SYK opened at $295.39 on Wednesday. The business’s 50-day simple moving average is $343.97 and its 200-day simple moving average is $356.28. The company has a market cap of $113.13 billion, a P/E ratio of 34.19, a PEG ratio of 1.72 and a beta of 0.80. Stryker Corporation has a one year low of $290.17 and a one year high of $404.87. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.25 and a current ratio of 2.11.

Stryker (NYSE:SYK – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The company had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. During the same quarter in the prior year, the company earned $2.84 EPS. The business’s revenue was up 2.6% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. As a group, equities research analysts expect that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Wall Street Zen upgraded shares of Stryker from a “hold” rating to a “buy” rating in a report on Saturday. Barclays decreased their price target on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday. JPMorgan Chase & Co. dropped their price objective on Stryker from $445.00 to $400.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Evercore set a $355.00 price objective on Stryker in a report on Friday. Finally, Leerink Partners started coverage on Stryker in a research note on Monday, April 13th. They set an “outperform” rating and a $410.00 target price on the stock. Sixteen equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Get Our Latest Stock Analysis on SYK

About Stryker

(Free Report)

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Stryker Corporation $SYK Shares Sold by LaFleur & Godfrey LLC

Stryker Trading Up 1.5%

Analyst Ratings Changes

About Stryker

See Also

You might be interested in: